Showing 171-180 of 3459 results for "".
Physician Spotlight: Stefan Weiss, MD
https://practicaldermatology.com/programs/practical-dermatology/physician-spotlight-stefan-weiss-md/24017/From enhancing the diagnosis and treatment of skin diseases to identifying unmet clinical needs, artificial intelligence (AI) and big data are upending the practice of dermatology.Close Up With Gil Yosipovitch, MD
https://practicaldermatology.com/columns/physician-spotlight/close-up-with-gil-yosipovitch-md/24002/Physician Spotlight: Shawn Kwatra, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-shawn-kwatra-md/23997/Physician Spotlight: Amy Paller, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-amy-paller-md/23449/Physician Spotlight: Lawrence Green, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-lawrence-green-md/23869/Physician Spotlight: Crystal Aguh, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-crystal-aguh-md/23234/Scientifically Speaking: Can We Conquer Cellulite?
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-can-we-conquer-cellulite/19872/Treating cellulite has been a challenge, but new and emerging technologies offer hope to overcome this common condition. Host Joel L. Cohen, MD talks with Nazanin Saedi, MD, Endo's Mike McLane, PhD, and Soliton's Wally Klemp.New Thinking: Eczema as a Systemic Disease
https://practicaldermatology.com/topics/psoriasis/new-thinking-eczema-as-a-systemic-disease/18756/By Seemal R. Desai, MD and Emma Guttman, MD, PhD, FAADEczema is an immune-driven disease like psoriasis. How is that knowledge changing the way that dermatologists treat patients? Are similar changes taking place for other inflammatory diseases? Dr. Guttman talks about the latest.DermWire TV: Maui Derm Highlights, Plus New and Emerging Treatments for HS and Acne
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-maui-derm-highlights-plus-new-and-emerging-treatments-for-hs-and-acne/20258/In this episode of DermWire TV, we recap the biggest news from Maui Derm 2024, including safety and efficacy studies on bimekizumab, deucravacitinib, and upadacitinib. Also from Maui Derm, Raj Chovatiya, MD, PhD, highlights new therapies to treat hidradenitis suppurativa and Julie Harper, MD, highliWhy Assessing Vitiligo Activity is Critical for Limiting Spread
https://practicaldermatology.com/conferences/maui-derm-2024/why-assessing-vitiligo-activity-is-critical-for-limiting-spread/20248/Chief Medical Editor Neal Bhatia, MD talks with “Mr. Vitiligo Himself,” John E. Harris, MD, PhD about the importance of determining whether vitiligo patients are active or stable in order to “shut off” spreading as soon as possible.